RxDoctor Payments DataLook up a doctor →

Surender Sandella, MD

Interventional Cardiology · New Albany, INNPI 1689736324

Payments from drug & device makers

$21,312in general payments, 2019–2025

Across 504 payments — averaging $42.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Penumbra, Inc.$3K
  • Boston Scientific$2K
  • Johnson & Johnson$2K
  • Inari Medical, Inc.$1K
  • Abiomed$809
  • plus $8K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott47$4,422
Penumbra, Inc.12$3,108
Boston Scientific32$1,916
Johnson & Johnson65$1,586
Inari Medical, Inc.25$1,272
Abiomed11$809
Stryker8$782
AstraZeneca23$765
E.r. Squibb & Sons, L.L.C.43$733
Merck34$626
Novartis41$489
Terumo Medical Corporation4$389
Pfizer24$382
Esperion Therapeutics, Inc.7$319
Amgen20$314
Osprey Medical Inc6$265
Philips North America LLC4$224
Amarin Pharma, Inc.7$199
Boehringer Ingelheim12$197
Shockwave Medical, Inc2$196
Bayer5$192
Medtronic(2 entities)6$191
Edwards Lifesciences1$171
Biotronik Inc.2$167
Chiesi USA, Inc.2$166
Cvrx, Inc.2$157
Sirtex Medical Inc1$140
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)11$126
AbbVie1$112
Regeneron Healthcare Solutions, Inc.6$110
Sanofi-aventis U.S. LLC6$96
Alnylam Pharmaceuticals Inc.3$66
Acist Medical Systems, Inc.3$65
Verge Medical, Inc.1$59
Vital Connect, Inc3$54
Altathera Pharmaceuticals LLC1$52
Lexicon Pharmaceuticals, Inc.3$43
Astellas Pharma US Inc3$43
Livanova USA, Inc.2$37
Cardiva Medical, Inc.2$36
GSK2$32
Atricure, Inc.1$32
Teleflex LLC1$25
Kiniksa Pharmaceuticals, Ltd.2$25
Otsuka America Pharmaceutical, Inc.1$20
Heartflow, Inc.1$19
Kiniksa Pharmaceuticals International, PLC1$18
Bard Peripheral Vascular, Inc.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$17
United Therapeutics Corporation1$16
Novo Nordisk1$14

How this compares

$21,312 in reported general payments places this provider in the 75th percentile of 170 interventional cardiology providers in Indiana.

See all interventional cardiology providers in Indiana →

Medicare billing

Part B allowed, 2024
$326,925
Medicare patients
1,290
Services billed
5,102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in New Albany

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →